loadpatents
name:-0.037060976028442
name:-0.0065670013427734
name:-0.00040483474731445
Bevec; Dorian Patent Filings

Bevec; Dorian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bevec; Dorian.The latest application filed is for "antimicrobial peptides for treatment of infectious diseases".

Company Profile
0.11.116
  • Bevec; Dorian - Germering N/A DE
  • Bevec; Dorian - US
  • Bevec; Dorian - Gentilino CH
  • Bevec; Dorian - US
  • Bevec; Dorian - Germeringde DE
  • Bevec, Dorian - Munich DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antimicrobial peptides for treatment of infectious diseases
Grant 9,044,426 - Hilpert , et al. June 2, 2
2015-06-02
Antimicrobial Peptides For Treatment Of Infectious Diseases
App 20140235531 - Hilpert; Kai ;   et al.
2014-08-21
Use of a octreotide as a therapeutic agent
Grant 8,541,364 - Bevec , et al. September 24, 2
2013-09-24
Use of Gonadorelin as a therapeutic agent
Grant 8,349,805 - Bevec , et al. January 8, 2
2013-01-08
Use of the peptide RFMWMR as a therapeutic agent
Grant 8,338,380 - Bevec , et al. December 25, 2
2012-12-25
Use of somatostatin-14 as a therapeutic agent
Grant 8,211,856 - Bevec , et al. July 3, 2
2012-07-03
Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine
Grant 8,193,149 - Bevec , et al. June 5, 2
2012-06-05
Formulation for aviptadil
Grant 8,178,489 - Bacher , et al. May 15, 2
2012-05-15
Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
Grant 7,951,778 - Bevec May 31, 2
2011-05-31
Use Of A Octreotide As A Therapeutic Agent
App 20110065630 - Bevec; Dorian ;   et al.
2011-03-17
Use Of Beta-melanotropin As A Therapeutic Agent, Eg For The Treatment Of Aids Or Alzheimer
App 20100323950 - Bevec; Dorian ;   et al.
2010-12-23
Use Of Glp-1 As A Therapeutic Agent
App 20100311643 - Bevec; Dorian ;   et al.
2010-12-09
Use Of Insulin C-peptide, Alone Or In Combination With Glp-1, As A Therapeutic Agent
App 20100292132 - Bevec; Dorian ;   et al.
2010-11-18
Use Of A Peptide As A Therapeutic Agent
App 20100286029 - Bevec; Dorian ;   et al.
2010-11-11
Use Of A Peptide As A Therapeutic Agent
App 20100286028 - Bevec; Dorian ;   et al.
2010-11-11
Use Of A Peptide As A Therapeutic Agent
App 20100273700 - Bevec; Dorian ;   et al.
2010-10-28
Use Of Salusin Beta Alone Or In Combination With Octreotide As A Therapeutic Agent
App 20100273701 - Bevec; Dorian ;   et al.
2010-10-28
Use Of A Peptide As A Therapeutic Agent
App 20100256043 - Bevec; Dorian ;   et al.
2010-10-07
Use Of Cnp-22, Alone Or In Combination With Physalemin, As A Therapeutic Agent
App 20100249017 - Bevec; Dorian ;   et al.
2010-09-30
Use Of A Peptide As A Therapeutic Agent
App 20100249019 - Bevec; Dorian ;   et al.
2010-09-30
Use Of A Peptide As A Therapeutic Agent
App 20100234306 - Bevec; Dorian ;   et al.
2010-09-16
Use Of Fibronectin Fragment (196-203 ) As A Therapeutic Agent
App 20100216724 - Bevec; Dorian ;   et al.
2010-08-26
Use Of The Peptide Pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys As A Therapeutic Agent
App 20100216722 - Bevec; Dorian ;   et al.
2010-08-26
Use Of The Peptide Combination Thymosin Beta 4 And Delta Sleep Inducing Peptide As A Therapeutic Agent
App 20100210540 - Bevec; Dorian
2010-08-19
Use Of Rfrp, Alone Or In Combination With Neurokinin-b, As A Therapeutic Agent
App 20100210557 - Bevec; Dorian
2010-08-19
Use Of A Tuftsin As A Therapeutic Agent
App 20100210567 - Bevec; Dorian
2010-08-19
Use Of Urocortin And Corticotropin-releasing Factor As Therapeutic Agents
App 20100210533 - Bevec; Dorian
2010-08-19
Therapeutic Use Of Neuropeptide Ei And Acth 7-38 And Compositions Thereof
App 20100210535 - Bevec; Dorian
2010-08-19
Trap-14 As A Therapeutic Agent
App 20100210559 - BEVEC; Dorian
2010-08-19
Use Of Il-1 Receptor Peptide, Alone Or In Combination With D-ala-gln-octadecyl Ester, As A Therapeutic Agent
App 20100210562 - Bevec; Dorian
2010-08-19
Use Of Neuropeptide Sf, Alone Or In Combination With Glp-2, As A Therapeutic Agent
App 20100210532 - Bevec; Dorian ;   et al.
2010-08-19
Use Of A Defensin Peptide As A Therapeutic Agent
App 20100210537 - Bevec; Dorian
2010-08-19
Therapeutic Uses Of Gastrin- 1 And G- Pen-grgdspca
App 20100210554 - Bevec; Dorian
2010-08-19
Therapeutic Uses Of Intermedin 47 And 53 Peptides
App 20100210538 - Bevec; Dorian ;   et al.
2010-08-19
Use Of Leptin (22-56 ) As A Therapeutic Agent
App 20100210536 - Bevec; Dorian ;   et al.
2010-08-19
Use Of A Peptide As A Therapeutic Agent
App 20100210534 - Bevec; Dorian
2010-08-19
Use Of Peptide Ll-37 As A Therapeutic Agent
App 20100210539 - Bevec; Dorian ;   et al.
2010-08-19
Use Of A Laminin Peptide As A Therapeutic Agent
App 20100210555 - Bevec; Dorian
2010-08-19
Thyrotropin Releasing Hormone For Therapeutic Applications
App 20100210568 - BEVEC; Dorian
2010-08-19
Use Of A Peptide As A Therapeutic Agent
App 20100210556 - BEVEC; Dorian
2010-08-19
Use Of Peptide As A Therapeutic Agent
App 20100210561 - Bevec; Dorian ;   et al.
2010-08-19
Minigastrin As A Therapeutic Agent
App 20100210558 - Bevec; Dorian ;   et al.
2010-08-19
Use Of The Peptide Asn-asp-asp-cys-glu- Leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu Alone Or In Combination With The Peptide Thr-thr-ser-gln-val- Arg-pro-arg As A Therapeutic Agent
App 20100210553 - Bevec; Dorian ;   et al.
2010-08-19
Use Of A Peptide As A Therapeutic Agent
App 20100204131 - BEVEC; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204157 - Bevec; Dorian
2010-08-12
Astressin And Beta- Endorphin For Use As Therapeutic Agents
App 20100204111 - BEVEC; Dorian
2010-08-12
Use Of Calcitonin As Anti-angiogenic Agent
App 20100204116 - Bevec; Dorian ;   et al.
2010-08-12
Gamma 1 Msh Alone Or In Combination With Pentagastrin As A Therapeutic Agent
App 20100204143 - Bevec; Dorian ;   et al.
2010-08-12
Use Of The Peptide Phpfhlfvy (renin Inhibitor) As A Therapeutic Agent
App 20100204142 - Bevec; Dorian
2010-08-12
Use Of Gluten Exorphin C : As A Therapeutic Agent
App 20100204152 - Bevec; Dorian ;   et al.
2010-08-12
Use Of C-type Natriuretic Peptide, Alone Or In Combination With Neuropeptide Af, As A Therapeutic Agent
App 20100204109 - Bevec; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204150 - Bevec; Dorian
2010-08-12
Use Of Trp6-triptorelin And D-leu6-leuprolide As Therapeutic Agents
App 20100204138 - BEVEC; Dorian
2010-08-12
Use Of Grf-1 (1-29 ) And Corticotropin-releasing Factor As Therapeutic Agents
App 20100204118 - Bevec; Dorian
2010-08-12
Use Of Neurotrophic Factor For Retinal Cholinergic Neurons (nfrcn) And Chorionic Gonadotropin-beta (109-145) As Therapeutic Agents
App 20100204108 - Bevec; Dorian ;   et al.
2010-08-12
Use Of Octreotide As A Therapeutic Agent
App 20100204149 - Bevec; Dorian ;   et al.
2010-08-12
Use Of The Peptide Sfllr-oh And Muramyl Dipeptide As Therapeutic Agents
App 20100204155 - Bevec; Dorian
2010-08-12
Use Of The Peptide Rfmwmr As A Therapeutic Agent
App 20100204154 - Bevec; Dorian
2010-08-12
Use Of Stresscopin-related Peptide As A Therapeutic Agent
App 20100204113 - BEVEC; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204145 - Bevec; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204140 - Bevec; Dorian
2010-08-12
Use Of The Peptide His-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe Alone Or In Combination With The Peptide Gly-ard-gly-asp-asn-pro-oh As A Therapeutic Agent
App 20100204134 - Bevec; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204090 - Bevec; Dorian ;   et al.
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204129 - Bevec; Dorian ;   et al.
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204110 - Bevec; Dorian
2010-08-12
Use Of The Peptides Maippkknqdk (cow Kappa Casein 106-116) And/or Ygfqna (serorphin) As Therapeutic Agents
App 20100204144 - Bevec; Dorian
2010-08-12
Use Of Gonadorelin As A Therapeutic Agent
App 20100204139 - Bevec; Dorian
2010-08-12
Use Of Thymopentin As A Therapeutic Agent
App 20100204156 - BEVEC; Dorian
2010-08-12
Use Of Acetyl- (ala10, 11)-rantes (1-14) And/or Calcitonin As Anti-angiogenic Agents
App 20100204115 - Bevec; Dorian
2010-08-12
Use Of A Galanin Peptide As A Therapeutic Agent
App 20100204114 - BEVEC; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204136 - Bevec; Dorian
2010-08-12
Use Of Human Neuropeptide As A Therapeutic Agent
App 20100204130 - Bevec; Dorian
2010-08-12
THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPC
App 20100204132 - Bevec; Dorian
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204151 - Bevec; Dorian
2010-08-12
(d-leu7 ) -histrelin As A Therapeutic Agent
App 20100204148 - Bevec; Dorian
2010-08-12
Cgrp As A Therapeutic Agent
App 20100204117 - Bevec; Dorian
2010-08-12
Use Of Lvv-hemorphin-6 And Optionally Af12198 As Therapeutic Agent(s)
App 20100204135 - Bevec; Dorian
2010-08-12
Use Of Urodilatin As A Therapeutic Agent
App 20100204107 - Bevec; Dorian
2010-08-12
Use Of Bpp-b As A Therapeutic Agent
App 20100204141 - Bevec; Dorian
2010-08-12
Combination Of Splenopentin And Thymopentin And The Use Thereof In Medicine
App 20100204158 - Bevec; Dorian
2010-08-12
Use Of Tyr-w-mif-1 And Urocortin 2 As Therapeutic Agents
App 20100204112 - Bevec; Dorian ;   et al.
2010-08-12
Use Of Band 3 Protein (824-829) And/or Melanocyte-stimulating Hormone Release-inhibiting Factor As A Therapeutic Agent In The Treatment Of Pseudomonas Aeruginosa Infection
App 20100204153 - Bevec; Dorian
2010-08-12
Therapeutic Use Of Peptide Yglf And Combination With Kvlpvpq
App 20100197605 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Rgd-peptide And/or Parathyroid Hormone (1-34) As Anti-hiv Agent
App 20100197585 - Bevec; Dorian ;   et al.
2010-08-05
Use Of The Peptide His-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe Alone Or In Combination With The Peptide Pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh As A Therapeutic Agent
App 20100197600 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Peptide As A Therapeutic Agent
App 20100197604 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Peptide As A Therapeutic Agent
App 20100197588 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Peptide As A Therapeutic Agent
App 20100197599 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Follicular Gonadotropin Releasing Peptide As A Therapeutic Agent In The Treatment Of Streptococcus Pneumoniae Infection
App 20100197602 - Bevec; Dorian
2010-08-05
Use Of A Peptide As A Therapeutic Agent
App 20100197587 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Rgdspasskp And Optionally Angiotensin Ii As Therapeutic Agents In The Treatment Of Eg S. Pneumoniae Infections
App 20100197603 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Melanotrophin-potentiating Factor As A Therapeutic Agent
App 20100197608 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Somatostatin-14 As A Therapeutic Agent
App 20100197572 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Fibrinogen Receptor Antagonist And/or Follicular Gonadotropin Releasing Peptide As A Therapeutic Agent In The Treatment Of Streptococcus Pneumonia Infection
App 20100197601 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Secretin And Optionally Urodilatin As Therapeutic Agents
App 20100197586 - Bevec; Dorian ;   et al.
2010-08-05
Big Gastrin I As A Therapeutic Agent
App 20100190711 - Bevec; Dorian ;   et al.
2010-07-29
Use Of Melanin Concentrating Hormone And Met-enkephalin As Therapeutic Agents
App 20100190717 - Bevec; Dorian ;   et al.
2010-07-29
Substance P And Thyrotropin Releasing Hormone For Therapeutic Applications
App 20100190722 - Bevec; Dorian ;   et al.
2010-07-29
Use Of The Peptide Thymosin Beta 4 Alone Or In Combination With Cecropin A As A Therapeutic Agent
App 20100190713 - Bevec; Dorian ;   et al.
2010-07-29
Use Of A Platelet Fibrinogen Receptor Hexapeptide Antagonist And Alpha-endorphin As Therapeutic Agents
App 20100190716 - Bevec; Dorian ;   et al.
2010-07-29
Use Of Peptide Yy, Alone Or In Combination With Glucagon-like Peptide, For Use In Medicine
App 20100190712 - Bevec; Dorian ;   et al.
2010-07-29
Use Of A Deslorelin And Mastoparan As A Therapeutic Agent
App 20100184698 - Bevec; Dorian ;   et al.
2010-07-22
Proadrenomedullin Alone Or In Combination With Big Gastrin I As A Therapeutic Agent
App 20100184674 - Bevec; Dorian ;   et al.
2010-07-22
Use Of A Peptide As A Therapeutic Agent
App 20100184676 - Bevec; Dorian ;   et al.
2010-07-22
Use Of Gly-pro-glu-oh (gpe) As A Therapeutic Agent
App 20100184708 - Bevec; Dorian ;   et al.
2010-07-22
Use Of A Peptide As A Therapeutic Agent
App 20100184678 - Bevec; Dorian ;   et al.
2010-07-22
Use Of Parathyroid Hormone ( 1-34 ) As Anti-hiv Agent
App 20100184673 - Bevec; Dorian
2010-07-22
Use Of A Combination Of Cart Peptides As A Therapeutic Agent
App 20100184679 - Bevec; Dorian
2010-07-22
Use Of The Human Pancreatic Polypeptide As A Therapeutic Agent
App 20100184677 - Bevec; Dorian ;   et al.
2010-07-22
Therapeutic Uses Of B-type Natriuretic Peptide And Human Growth Hormone 1-43
App 20100184680 - Bevec; Dorian
2010-07-22
Use Of Glucagon (1-29) Alone Or In Combination With Neuropeptide W30 As A Therapeutic Agent
App 20100184675 - Bevec; Dorian
2010-07-22
Use Of The Peptide Gly-arg-gly-asp-asn-pro As A Therapeutic Agent
App 20100184704 - Bevec; Dorian
2010-07-22
Use Of Fertirelin And Delta-endorphin As Therapeutic Agents
App 20100173845 - Bevec; Dorian
2010-07-08
Compositions And Methods For Treatment Of Chronic Fatigue Syndrome And Neurodegenerative Diseases
App 20100063251 - Bevec; Dorian
2010-03-11
Novel Pharmaceutical Composition Of Interferon Gamma Or Pirfenidone With Molecular Diagnostics For The Improved Treatment Of Interstitial Lung Diseases
App 20090142301 - Bevec; Dorian ;   et al.
2009-06-04
Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung diseases
Grant 7,468,353 - Bevec December 23, 2
2008-12-23
Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
App 20080274961 - Bevec; Dorian
2008-11-06
Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
App 20060270618 - Bevec; Dorian
2006-11-30
Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
App 20060241028 - Bevec; Dorian
2006-10-26
Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections
App 20060223748 - Bevec; Dorian
2006-10-05
Pharmaceutically active aromatic guanylhydrazones
App 20050171176 - Bevec, Dorian ;   et al.
2005-08-04
Cellular kinases involved in Cytomegalovirus infection and their inhibition
Grant 6,849,409 - Schubart , et al. February 1, 2
2005-02-01
Use of specific compounds particularly kinase inhibitors for treating viral infections
App 20040122058 - Bevec, Dorian ;   et al.
2004-06-24
Pharmaceutically active aromatic guanylhydrazones
App 20030203969 - Bevec, Dorian ;   et al.
2003-10-30
Cellular kinases involved in Cytomegalovirus infection and their inhibition
App 20030082519 - Schubart, Daniel ;   et al.
2003-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed